DigestRedComo funciona
Red
/
Empresas
Si
No verificado

Sironax USA, Inc.

Sobre qué escribimos

BiotecnologíaMedicina Salud Bienestar

6 Comunicados de prensa

Ver todos los comunicados de prensa
11/05/2026
Biotecnología
Sironax’s SARM1 Inhibitor SIR2501 Granted FDA Fast Track Designation in Chemotherapy-induced Peripheral Neuropathy (CIPN)
Fuente
Sironax USA, Inc.
Editor
GLOBENEWSWIRE
1.00
0
22/04/2026
Biotecnología
Sironax Announces Abstract on SARM1 Inhibitor SIR2501 Selected for Presentation at 2026 ASCO Annual Meeting
Fuente
Sironax USA, Inc.
Editor
GLOBENEWSWIRE
1.00
0
26/03/2026
Biotecnología
Sironax Appoints Clive Wang to Board of Directors
Fuente
Sironax USA, Inc.
Editor
GLOBENEWSWIRE
1.00
0
20/03/2026
Biotecnología
Sironax Announces Upcoming Poster Presentation on NAMPT Activation
Fuente
Sironax USA, Inc.
Editor
GLOBENEWSWIRE
1.00
0
06/11/2025
Biotecnología
Medicina Salud Bienestar
Sironax Announces Three Abstracts Selected for Presentation at Neuroscience 2025
Fuente
Sironax USA, Inc.
Editor
GLOBENEWSWIRE
1.00
0
22/10/2025
Biotecnología
Medicina Salud Bienestar
Sironax Announces Key Leadership Appointments to Advance Global Drug Discovery and Development
Fuente
Sironax USA, Inc.
Editor
GLOBENEWSWIRE
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0